Follow
Together with FDA and @HochreiterSepp's IARAI we've been working on an #NLP-oriented challenge that is focused on tracking safety of the drug after clinical trials.
Submit before 16th may to join us at @CAMDA_conf 2022 in Wisconsin!
https://bipress.boku.ac.at/camda2022/
